×

Cookie Settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operations of the website, as well as cookies that are only used for anonymous statistical purposes, for comfort settings or to display personalized content. Please note that based on your settings, it is possible that not all functionalities of the website will be available. You can find further information in our privacy policy.

Please make your personal preference here:

Imprint

 
 
Shopping Cart - CHF 0.00

You have no items in your shopping cart.

  • Home  » 
  • 4017147
Return to Previous Page
4017147

Availability: In stock

pTH-Related Protein (1-34) (human, mouse, rat)
H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-OH

4017147

Product No. Pack Size Available ADS InfoAnalytical Data Sheet List Price Online Order Price Qty
4017147.0500 0.5 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 200.00
CHF 186.00 (7%)
4017147.1000 1 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 368.00
CHF 342.24 (7%)

Details

V.Paspaliaris et al. showed that daily administration of pTHrP (1-34) to rats was anabolic on bone by increasing bone formation. This treatment could inhibit the rapid decline in bone formation due to denervation.
Catalog Number H-6630
APC Number 22-1-74
One Letter Code AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA
Synonyms Hypercalcemia of Malignancy Factor (1-34) (human, mouse, rat), pTHrP (1-34) (human, mouse, rat)
Molecular Formula C₁₈₀H₂₈₇N₅₇O₄₈
Relative Molecular Mass 4017.61
CAS Registry Number 112540-82-6
Source Synthetic
Storage Conditions -20 ± 5 °C
Application Osteoporosis Research
Links / Documents:

Bachem product citations

W.Zhang et al., Arch. Oral Biol., 83, 13 (2017)
S.Chukkapalli et al., Endocrine, 51, 534 (2016)
A.López-Herradón et al., Rev. Osteoporos. Metab. Miner., 6, 46 (2014)
A.Y.Jun et al., Invest. New Drugs, 32, 1 (2014)
J.Fischer et al., Stem Cells Dev., 23, 2513 (2014)
I.W.Mak et al., J. Bone Miner. Res., 27, 1976 (2012)
I.W.Mak et al., J. Bone Miner. Res., 27, 1976 (2012)
J.Liu and S.A.McLuckey, Int. J. Mass Spectrom., 330, 174 (2012)
J.M.Lee and G.I.Im, Biochem. Biophys. Res. Commun., 421, 819 (2012)
R.W.Cowan et al., J. Orthop. Res., 30, 877 (2012)
N.S.Datta et al., Cell Signal., 22, 457 (2010)
M.Schnoke et al., Bone, 45, 590 (2009)
J.E.Berry et al., Oral Dis., 14, 713 (2008)
A.Dittmer et al., J. Biol. Chem., 281, 14563 (2006)
R.Kumari et al., Int. J. Cancer, 119, 49 (2006)
H.Fukushima et al., Bone, 36, 267 (2005)
J.J.Grzesiak et al., Int. J. Cancer, 114, 522 (2005)
L.Rodriguez et al., Endocrinology, 146, 4597 (2005)
L.P.Rubin et al., Dev. Dyn., 230, 278 (2004)
A.Errazahi et al., J. Bone Miner. Res., 18, 737 (2003)
J.L.Funk et al., Arthritis Rheum., 48, 1721 (2003)
P.Misiano et al., Eur. J. Pharmacol., 469, 159 (2003)
R.H.Hastings et al., Am. J. Respir. Cell Mol. Biol., 29, 733 (2003)
C.Faucheux et al., J. Bone Miner. Res., 17, 455 (2002)
D.Zhang et al., J. Bone Miner. Res., 17, 293 (2002)
C.Farquharson et al., Endocrinology, 142, 4131 (2001)
J.Alvarez et al., Dev. Dyn., 221, 311 (2001)
K.D.Schluter et al., Br. J. Pharmacol., 132, 427 (2001)
A.F.Ruchon et al., J. Bone Miner. Res., 15, 1266 (2000)
C.Wu et al., Mol. Cell. Endocrinol., 170, 163 (2000)
R.Serra et al., J. Cell Biol., 145, 783 (1999)
S.Morony et al., J. Bone Miner. Res., 14, 1478 (1999)

Product citations

V.Paspaliaris et al., Bone, 16, 141S, abstract (1995)
B.E.Kemp et al., Science, 238, 1568 (1987)
J.M.Moseley et al., Proc. Natl. Acad. Sci. USA, 84, 5048 (1987)
L.J.Suva et al., Science, 237, 893 (1987)
Related products